Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “hydrogen peroxide”

7 pharma patents match "hydrogen peroxide" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "hydrogen peroxide" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “hydrogen peroxide” · 30,257 patents in full index Clear search

  1. US 12383535

    Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  2. US 9713459

    Method and system for in vivo hydrogen peroxide detection with ultrasound

    The Regents of the University of California · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted
  3. US 9333264

    Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide

    The Regents of the University of California · Granted May 10, 2016 · Expires May 5, 2036

    granted
  4. US 6375946

    Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

    Maxim Pharmaceuticals, Inc. · Granted Apr 23, 2002 · Expires Apr 18, 2022

    expired
  5. US 6245563

    Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor

    Maxim Pharmaceuticals, Inc. · Granted Jun 12, 2001 · Expires Jun 7, 2021

    expired
  6. US 6071509

    Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

    Maxim Pharmaceuticals, Inc. · Granted Jun 6, 2000 · Expires Jun 1, 2020

    expired
  7. US 6063373

    Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

    Maxim Pharmaceuticals, Inc. · Granted May 16, 2000 · Expires May 11, 2020

    expired